Written Question·Department of Health and Social Care·UIN 96433
Glioblastoma: Immunotherapy
Tabled: 2 December 2025
Answered: 8 December 2025
Question
Jack Rankin
Conservative — Windsor
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential merits of DCVax-L following its trial at King’s College Hospital.
Answer
Dr Zubir AhmedThe Department has made no assessment of the potential merits of DCVax-L following its trial at King’s College Hospital.Northwest Biotherapeutics has submitted a Marketing Authorisation Application to the Medicines and Healthcare products Regulatory Agenc...
ⓘ
This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 96433) →